Cleveland Diagnostics

Cleveland Diagnostics (formerly AnalizaDx) is developing applications of its proprietary platform for the in vitro cancer diagnostic market. The technology is a fundamentally different method for biomarker identification and quantification that addresses the clinical problems posed by natural biological variation in protein levels.

Funding: JumpStart, Strategic Partner

Stage: Preclinical

News: Cleveland Diagnostics Announces Preliminary Results From Multicenter IsoPSA Study